SUVEN
Suven Life Sciences Limited
Healthcare Research, Analytics & Technology
Share price
₹373
Market cap
₹9,831 Cr
1Y return
▲ 59%
A clinical-stage biopharmaceutical company engaged in the acquisition, development, and commercialization of novel therapeutics for treating neurodegenerative disorders. Suven Life Sciences operates across research, analytics, and technology platforms to advance its pipeline of investigational drugs targeting diseases affecting the nervous system. The company focuses on bringing innovative treatment solutions to patients suffering from neurological conditions through rigorous clinical development processes.
Investors holding Suven Life Sciences Limited
Latest move
Quant Mutual FundExited
Quant Mutual Fund has dropped from Suven Life Sciences Limited's disclosed shareholder list after previously holding 1.78 percent, indicating either a complete exit or a reduction of its stake to below the 1 percent reporting requirement.
Sign in to read more
Whales made 2 more moves in Suven Life Sciences Limited
Sign in to see who is buying and selling.
Sign in to find out